wiki pageCreated: 2026-04-02T07:19:04By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-mfsd8-protein
📖 Wiki Page
protein765 wordssynced 2026-04-02
MFSD8 Protein (CLN7)
Introduction
MFSD8 (Major Facilitator Superfamily Domain-containing protein 8, also CLN7; encoded by the [MFSD8 gene](/genes/mfsd8)) is a lysosomal membrane transporter implicated in neuronal ceroid lipofuscinosis type 7 (CLN7 disease), a devastating pediatric neurodegenerative disorder.
Overview
MFSD8 is a 518-amino acid polytopic membrane protein belonging to the major facilitator superfamily (MFS) of transporters, localized primarily to the lysosomal membrane<sup>[1]</sup>. While its precise substrate(s) remain under investigation, MFSD8 is believed to transport small molecules (possibly chloride or other ions) across the lysosomal membrane, maintaining lysosomal homeostasis<sup>[2]</sup>. Biallelic loss-of-function mutations cause CLN7 disease (neuronal ceroid lipofuscinosis type 7), characterized by progressive vision loss, seizures, motor deterioration, and cognitive decline<sup>[3]</sup>. [@damme2014]
MFSD8 has a typical MFS transporter fold<sup>[1]</sup>:
...
MFSD8 Protein (CLN7)
Introduction
MFSD8 (Major Facilitator Superfamily Domain-containing protein 8, also CLN7; encoded by the [MFSD8 gene](/genes/mfsd8)) is a lysosomal membrane transporter implicated in neuronal ceroid lipofuscinosis type 7 (CLN7 disease), a devastating pediatric neurodegenerative disorder.
Overview
MFSD8 is a 518-amino acid polytopic membrane protein belonging to the major facilitator superfamily (MFS) of transporters, localized primarily to the lysosomal membrane<sup>[1]</sup>. While its precise substrate(s) remain under investigation, MFSD8 is believed to transport small molecules (possibly chloride or other ions) across the lysosomal membrane, maintaining lysosomal homeostasis<sup>[2]</sup>. Biallelic loss-of-function mutations cause CLN7 disease (neuronal ceroid lipofuscinosis type 7), characterized by progressive vision loss, seizures, motor deterioration, and cognitive decline<sup>[3]</sup>. [@damme2014]
MFSD8 has a typical MFS transporter fold<sup>[1]</sup>:
12 transmembrane helices (TMs): Arranged in two 6-TM bundles (N-domain: TM1-6; C-domain: TM7-12)
Central cavity: Formed between the N- and C-domains; likely substrate-binding site
MFS signature motif: Conserved sequence in the cytoplasmic loop between TM2-TM3
N-glycosylation sites: Present on intra-lysosomal loops
Cytoplasmic termini: Short N- and C-terminal tails in the cytoplasm
Transport Mechanism
MFS transporters typically operate through an alternating access mechanism:
Outward-open (lysosomal lumen-facing): Substrate binds in the central cavity
Occluded state: Both sides of the transporter are closed
Inward-open (cytoplasm-facing): Substrate released into the cytoplasm
Reset: Returns to outward-open state
Function
Lysosomal Homeostasis
MFSD8 contributes to lysosomal function through<sup>[2]</sup>:
Ion/metabolite transport: Maintains lysosomal ionic balance and membrane potential
Lysosomal pH regulation: May participate in counter-ion transport supporting v-ATPase function
[Autophagy](/entities/autophagy) support: Required for efficient autophagic degradation
Lysosomal biogenesis: Loss of MFSD8 impairs [TFEB](/proteins/tfeb-protein)-mediated lysosomal gene expression
Neuronal Importance
MFSD8 is particularly important in [neurons](/entities/neurons)<sup>[3]</sup>:
Synaptic maintenance: Lysosomal function is critical for synaptic protein turnover
Lipofuscin clearance: Prevents accumulation of autofluorescent storage material (ceroid lipofuscin)
Proteolipid processing: Required for proper degradation of subunit c of mitochondrial ATP synthase (SCMAS)
Disease Associations
CLN7 Disease (Neuronal Ceroid Lipofuscinosis Type 7)
CLN7 disease is an autosomal recessive lysosomal storage disorder<sup>[3]</sup>:
| Feature | Description | |---------|-------------| | Inheritance | Autosomal recessive | | Onset | 2-7 years (late infantile to juvenile variant) | | Vision | Progressive retinal degeneration → blindness | | Seizures | Intractable epilepsy (myoclonic, tonic-clonic) | | Motor | Progressive spasticity, ataxia, loss of ambulation | | Cognition | Progressive dementia | | Storage material | Curvilinear and fingerprint profiles on EM; SCMAS accumulation | | Prognosis | Fatal, typically in the second decade |
Neuropathology
CLN7 disease shows<sup>[4]</sup>:
Massive neuronal loss: Particularly in [cortex](/brain-regions/cortex) and cerebellum
Autofluorescent storage material: Ceroid lipofuscin in lysosomes of neurons and other cells
SCMAS accumulation: Subunit c of mitochondrial ATP synthase in lysosomal storage bodies
Astrocytosis and microglial activation: Prominent neuroinflammation
Retinal degeneration: Photoreceptor and ganglion cell loss
Connections to Neurodegeneration
CLN7 disease pathobiology intersects with common neurodegenerative mechanisms<sup>[2]</sup>:
Lysosomal dysfunction: Shared with [GBA1](/genes/gba1)-linked [Parkinson's disease](/diseases/parkinsons-disease) and [NPC1](/genes/npc1)-linked Niemann-Pick
Autophagy failure: Common endpoint in [AD](/diseases/alzheimers-disease), PD, and lysosomal storage diseases
Neuroinflammation: Microglial activation and astrogliosis parallel adult-onset neurodegeneration
Heterozygous carrier risk: Some NCL gene heterozygotes may have elevated risk for late-onset neurodegeneration
Therapeutic Implications
Gene therapy: AAV-mediated MFSD8 delivery under investigation for CLN7 disease
Enzyme replacement: Not applicable (MFSD8 is a membrane transporter, not a soluble enzyme)
Small molecule chaperones: May stabilize partially functional mutants
Anti-inflammatory therapy: Targeting neuroinflammation as symptomatic approach
Substrate reduction: Reducing accumulation of storage material
[Siintola E et al., The novel neuronal ceroid lipofuscinosis gene MFSD8 encodes a putative lysosomal transporter (2007) (2007)](https://doi.org/10.1086/521110)
[Damme M et al., Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease (2014) (2014)](https://doi.org/10.1016/j.nbd.2014.07.001)
[Aldahmesh MA et al., Neuronal ceroid lipofuscinosis caused by MFSD8 mutations: a common late-infantile variant (2009) (2009)](https://doi.org/10.1212/WNL.0b013e31819c67d2)
[Kousi M et al., Mutations in CLN7/MFSD8 are a common cause of variant late-infantile neuronal ceroid lipofuscinosis (2009) (2009)](https://doi.org/10.1093/brain/awp052)